VAERS Explorer
Back to explore

Report #2873440

Received Nov 18, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
74 yrs
State
MD
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
TDAPTDAP (ADACEL)SANOFI PASTEURUNK—OT

Symptoms (2)

No adverse eventProduct administered to patient of inappropriate age

Symptom narrative

patient is 74 years old was administered to Adacel with no reported adverse event; Initial information received on 12-Nov-2025 regarding an unsolicited valid non-serious case received from a physician. This case involves a 74 years old and unknown gender patient who was administered to Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine [Adacel], with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received 0.5mL of suspect Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine, Suspension for injection (lot number, expiry date and strength not reported) via intramuscular route in unknown administration site for prophylactic vaccination (Immunisation), with no reported adverse event (product administered to patient of inappropriate age) (latency same day). Information on the batch number was requested corresponding to the one at time of event occurrence. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.